Skip to main content

Ulloa Navas, Ana Daniela

Institutions of which they are part

Predoctoral researcher
Rheumatology
Vall Hebron Institut de Recerca

Ulloa Navas, Ana Daniela

Institutions of which they are part

Predoctoral researcher
Rheumatology
Vall Hebron Institut de Recerca

Related news

The new therapeutic strategy aims at maintaining the efficacy of thalidomide while avoiding its main systemic adverse effects.

The event, held as part of World Lupus Day, incorporated the perspective of people living with the disease to address the challenges associated with lupus.

The global biopharmaceutical company UCB has acquired the data and clinical knowledge business of IMIDomics, a spin-off of the Vall d’Hebron Institute of Research (VHIR).

Related professionals

Mª Jose Moreno Negreie

Mª Jose Moreno Negreie

Molecular Imaging and Therapy
Read more
Gianluca Pellino

Gianluca Pellino

Main researcher
General Surgery
Read more
Cristina Gamez Cenzano

Cristina Gamez Cenzano

Senior researcher
Molecular Imaging and Therapy
Read more
Roger Domingo Espinós

Roger Domingo Espinós

Research technician
Stroke research
Read more

Subscribe to our newsletters and be part of the Campus life

We are a world-leading healthcare complex where healthcare, research, teaching and innovation go hand in hand.

CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.